Terms: = Thyroid cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Treatment
55 results:
1. Telocinobufagin, a PLK1 suppressor that inhibits tumor growth and metastasis by modulating CDC25c and CTCF in HNSCC cells.
Li J; Ma R; Lv JL; Ren YS; Tan YJ; Wang HM; Wang ZE; Wang BS; Yu JN; Wang YL; Tian J; Zheng QS
Phytomedicine; 2024 May; 127():155440. PubMed ID: 38452691
[TBL] [Abstract] [Full Text] [Related]
2. Combined treatment with
Huang S; Cui M; Wang R; Yang G; Wang N; Cui L; Ma G
Nucleosides Nucleotides Nucleic Acids; 2023; 42(9):731-742. PubMed ID: 36924446
[TBL] [Abstract] [Full Text] [Related]
3. The importance of vitamin D in the diagnosis and treatment of adenomyosis.
Moldassarina RS; Manabayeva GK; Akylzhanova ZY; Rashidova AM
Mol Cell Biochem; 2023 Mar; 478(3):571-579. PubMed ID: 35951150
[TBL] [Abstract] [Full Text] [Related]
4. Advances in targeted therapy for anaplastic thyroid carcinoma.
Qian C; Jiang L; Xu S; Wang J; Tan Z; Xin Y; Ge M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 50(6):685-693. PubMed ID: 35347921
[TBL] [Abstract] [Full Text] [Related]
5. miR-335-5p Inhibits Progression of Uterine Leiomyoma by Targeting ARGLU1.
Zhao W; Zhao Y; Chen L; Sun Y; Fan S
Comput Math Methods Med; 2022; 2022():2329576. PubMed ID: 35082911
[TBL] [Abstract] [Full Text] [Related]
6. Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma.
Nastoupil LJ; Chin CK; Westin JR; Fowler NH; Samaniego F; Cheng X; Ma MCJ; Wang Z; Chu F; Dsouza L; Obi C; Mims J; Feng L; Zhou S; Green M; Davis RE; Neelapu SS
Blood Adv; 2022 Feb; 6(4):1143-1151. PubMed ID: 35015819
[TBL] [Abstract] [Full Text] [Related]
7. Clinical efficacy with dabrafenib and trametinib in a T599_V600insT poorly differentiated metastatic thyroid carcinoma.
Lee CS; Miao E; Das K; Seetharamu N
BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34413035
[TBL] [Abstract] [Full Text] [Related]
8. [Application of BRAF in the diagnosis and treatment of thyroid papillary carcinoma].
Zou T; Pan Y; Wang LX
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):629-634. PubMed ID: 34289553
[TBL] [Abstract] [Full Text] [Related]
9. Double-Needle Lavage for Effective treatment of Difficult-Aspiration thyroid Cystic Nodules: A Single-Center Controlled Trial.
Xiaoyin T; Ping L; Bingwei L; Min D; Yan L; Bo Z
J Vasc Interv Radiol; 2020 Oct; 31(10):1675-1681. PubMed ID: 32948387
[TBL] [Abstract] [Full Text] [Related]
10. Pembrolizumab for anaplastic thyroid cancer: a case study.
Aghajani MJ; Cooper A; McGuire H; Jeffries T; Saab J; Ismail K; de Souza P; Bray V; Fazekas de St Groth B; Niles N; Roberts TL
Cancer Immunol Immunother; 2019 Dec; 68(12):1921-1934. PubMed ID: 31637475
[TBL] [Abstract] [Full Text] [Related]
11. Increased cytoplasmatic expression of cancer immune surveillance receptor CD1d in anaplastic thyroid carcinomas.
Weber F; Junger H; Werner JM; Velez Char N; Rejas C; Schlitt HJ; Hornung M
Cancer Med; 2019 Nov; 8(16):7065-7073. PubMed ID: 31560833
[TBL] [Abstract] [Full Text] [Related]
12. [Analysis of chyle leakage after central lymph node dissection for thyroid carcinoma].
Feng JL; Zhou QY; Chen J; Wang JD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Aug; 54(8):597-600. PubMed ID: 31434373
[No Abstract] [Full Text] [Related]
13. [Clinical value of BRAF V600E in thyroid carcinoma and the effect of telomerase reverse transcriptase promoter mutations].
Zhao C; Jia Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2019 Apr; 36(2):338-342. PubMed ID: 31016954
[TBL] [Abstract] [Full Text] [Related]
14. RET Kinase-Regulated MicroRNA-153-3p Improves Therapeutic Efficacy in Medullary thyroid Carcinoma.
Joo LJS; Weiss J; Gill AJ; Clifton-Bligh R; Brahmbhatt H; MacDiarmid JA; Gild ML; Robinson BG; Zhao JT; Sidhu SB
Thyroid; 2019 Jun; 29(6):830-844. PubMed ID: 30929576
[No Abstract] [Full Text] [Related]
15. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary thyroid Carcinoma Cells.
Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
[TBL] [Abstract] [Full Text] [Related]
16. Intravascular Large B-Cell Lymphoma Within a thyroid Nodule: A Diagnostic Pitfall.
Linnik Y; Nicka C; Lansigan F; Loo E; Liu X
Int J Surg Pathol; 2018 Aug; 26(5):428-431. PubMed ID: 29569516
[TBL] [Abstract] [Full Text] [Related]
17. Theranostic radiopharmaceuticals: established agents in current use.
Ballinger JR
Br J Radiol; 2018 Nov; 91(1091):20170969. PubMed ID: 29474096
[TBL] [Abstract] [Full Text] [Related]
18. A retrospective study of optimal surgical management for occult breast carcinoma: Mastectomy or quadrantectomy?
Huang Y; Wu H; Luo Z
Medicine (Baltimore); 2017 Dec; 96(52):e9490. PubMed ID: 29384945
[TBL] [Abstract] [Full Text] [Related]
19. A Review of Primary thyroid Lymphoma: Molecular Factors, Diagnosis and Management.
Pavlidis ET; Pavlidis TE
J Invest Surg; 2019 Mar; 32(2):137-142. PubMed ID: 29058491
[TBL] [Abstract] [Full Text] [Related]
20. Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits thyroid cancer Growth and Metastases.
Kotian S; Zhang L; Boufraqech M; Gaskins K; Gara SK; Quezado M; Nilubol N; Kebebew E
Clin Cancer Res; 2017 Sep; 23(17):5044-5054. PubMed ID: 28600475
[No Abstract] [Full Text] [Related]
[Next]
